● Recruiting

A Trial of Tegileridine Fumarate Lnjection for Prolonged Mechanical Ventilation Abirritation in the Intensive Care Unit (ICU)

Condition: Abirritation in the ICU · Sponsor: Jiangsu HengRui Medicine Co., Ltd.

PhasePhase 2

Planned participants120

Who can joinAll sexes, 18 Years to 85 Years

Healthy volunteersNo

About this study

The purpose of this study is to evaluate the efficacy and safety of Tegileridine Fumarate lnjection for prolonged abirritation(48h to 72h) during mechanical ventilation in the ICU.

This description comes directly from the study's public registry record.

Talk to the study team

Lei Tang · +0518-82342973 · ei.tang.lt31@hengrui.com

Always discuss trial participation with your own doctor first.

Locations (2)

Zhongshan Hospital	Shanghai, Shanghai Municipality, China	Recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Hubei, Wuhan, China	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07372924